Previous 10 | Next 10 |
home / stock / pfe / pfe articles
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
Pfizer Inc (NYSE: PFE) stock is up 1.7% at $27.04 at last check, following news a late-stage trial of its respiratory syncytial virus (RS...
The global market study pneumococcal conjugate (PCV) market is ~$8 billion per year, and Vaxcyte Inc (NASDAQ:PCVX) estimates it will grow...
In a strategic move to strengthen economic ties, Japanese Prime Minister Fumio Kishida has reached out to American business leaders, advocating for...
Tuesday, Pfizer Inc (NYSE:PFE) released top-line immunogenicity and safety data from the ongoing pivotal Phase 3 MONeT trial, evalua...
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said Amazon.com, Inc. (NASDAQ: AMZN) is on the cus...
Wednesday, the New England Journal of Medicine published full study data from the Phase 2/3 trial of Pfizer Inc’s (NYSE:P...
Sanofi SA (NASDAQ:SASY) has announced an agreement in principle to settle approximately 4,000 lawsuits in the United States linked to the...
AstraZeneca Plc’s (NASDAQ:AZN) Chief Executive Pascal Soriot says the company achieved a significant milestone by reaching a s...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...
2024-07-18 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...